Coronary artery calcium and incident cerebrovascular events in an asymptomatic cohort the MESA study

JACC: Cardiovascular Imaging

Volumn 7, Issue 11, 2014, Pages 1108-1115

  Gibson, Ashleigh O ^a   Blaha, Michael J ^b   Arnan, Martinson K ^a   Sacco, Ralph L ^c   Szklo, Moyses ^d   Herrington, David M ^a   Yeboah, Joseph ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cerebrovascular disease; Coronary artery calcium score; Prevention; Risk prediction

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CORONARY ARTERY CALCIUM SCORE; ETHNICITY; EVENT FREE SURVIVAL; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OCCLUSIVE CEREBROVASCULAR DISEASE; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; TRANSIENT ISCHEMIC ATTACK; ANGIOCARDIOGRAPHY; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DISCRIMINANT ANALYSIS; DISEASE FREE SURVIVAL; ETHNOLOGY; INCIDENCE; ISCHEMIC ATTACK, TRANSIENT; KAPLAN MEIER METHOD; MULTICENTER STUDY; MULTIDETECTOR COMPUTED TOMOGRAPHY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; STROKE; TIME; UNITED STATES; VASCULAR CALCIFICATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ASYMPTOMATIC DISEASES; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DISCRIMINANT ANALYSIS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INCIDENCE; ISCHEMIC ATTACK, TRANSIENT; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STROKE; TIME FACTORS; UNITED STATES; VASCULAR CALCIFICATION;

EID: 84922541611     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2014.07.009     Document Type: Article

References (35)

1. Newman AB, Naydeck BL, Ives DG, et al. Coronary artery calcium, carotid artery wall thickness, and cardiovascular disease outcomes in adults 70 to 99 years old. Am J Cardiol 2008;101:186-92.
2. Folsom AR, Kronmal RA, Detrano RC, et al. Coronary artery calcification compared with carotid intima media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch InternMed 2008;168:1333-9.
3. Elias-Smale SE, Wieberdink RG, Odink AE, et al. Burden of atherosclerosis improves the prediction of coronary heart disease but not cerebrovascular events: the Rotterdam Study. Eur Heart J 2011;32: 2050-8.
4. Yeboah J, McClelland RL, Polonsky TS, et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate risk individuals. JAMA 2012;308:788-95.
5. Kavousi M, Elias-Smale S, Rutten JH, et al. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann Intern Med 2012;156:438-44.
6. Polonsky TS, McClelland RL, Jorgensen NW, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 2010;303:1610-6.
7. Kavousi M, Leening MJG, Witterman JCM. Markers for prediction of cardiovascular risk. JAMA 2012;308:2561-2.
8. Goff DC Jr., Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:2935-59.
9. D'Agostino RB Sr., Grundy S, Sullivan LM, Wilson P, CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001;286:180-7.
10. Hermann DM, Gronewold J, Lehmann N, et al., Heinz Nixdorf Recall Study Investigative Group. Coronary artery calcification is an independent stroke predictor in the general population. Stroke 2013;44:1008-13.
11. Bild DE, Bluemke DA, Burke GL, et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol 2002;156:871-81.
12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18: 499-502.
13. Carr JJ, Nelson JC, Wong ND, et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology 2005; 234:35-43.
14. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15: 827-32.
15. D'Agostino RB, Wolf PA, Belenger AJ, Kannel WB. Stroke risk profile. Adjustment for antihypertensive medications: The Framingham Heart Study. Stroke 1994;25:40-3.
16. Hlatky MA. Framework for evaluating novel risk markers. Ann Intern Med 2012;156:468-9.
17. Simons DB, Schwartz RS, Edwards WD, Sheedy PF, Breen JF. Non-invasive definition of anatomic coronary disease by ultrafast computed tomography: a quantitative pathologic comparison study. J Am Coll Cardiol 1992;20:1118-26.
18. Lahoz C, Carlos JM III. Atherosclerosis as a systemic disease. Rev Esp Cardiol 2007;60: 184-95.
19. Tison GH, Blaha MJ, Nasir K. Atherosclerosis imaging in multiple vascular beds-enough heterogeneity to improve risk prediction Atherosclerosis 2011;214:261-3.
20. Mohr JP, Albers GW, Amarenco P, et al. Etiology of stroke. Stroke 1997;28:1501-6.
21. Go AS, Mozaffarian D, Roger VL, et al., American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013;127: e6-245.
22. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72.
23. Whelton PK, He J, Appel LJ, et al. Primary prevention of hypertension: clinical and public health advisory from the National High Blood Pressure Education Program. JAMA 2002;288: 1882-8.
24. Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, Weiss NS. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-Analysis. JAMA 2003;289:2534-44.
25. Turnbull F. Effects of different bloodpressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet 2003; 362:1527-35.
26. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-Analysis of 147 randomized trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338:b1665.
27. Horenstein RB, Smith DE, Mosca L. Cholesterol predicts stroke mortality in the Women's Pooling Project. Stroke 2002;33:1863-8.
28. Kurth T, Everett BM, Buring JE, Kase CS, Ridker PM, Gaziano JM. Lipid levels and the risk of ischemic stroke in women. Neurology 2007;68: 556-62.
29. Shahar E, Chambless LE, Rosamond WD, et al. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2003;34:623-31.
30. Bots ML, Elwood PC, Nikitin Y, et al. Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centers in Europe. J Epidemiol Community Health 2002;56: i19-24.
31. Amarenco P, Labreuche J, Lavallee P, Touboul PJ. Statins in stroke prevention and carotid atherosclerosis: systematic review and upto-date meta-Analysis. Stroke 2004;35:2902-9.
32. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-Analysis of data from 90,056 participants in 14 randomized trials of statins. Lancet 2005;366:1267-78.
33. Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-Analysis of statins for stroke prevention. Lancet Neurol 2009;8:453-63.
34. Sever PS, Dahlöf B, Poulter NR, et al., ASCOT Investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-Average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomized controlled trial. Lancet 2003;361:1149-58.
35. EverettBM,Glynn RJ,MacFadyen JG, RidkerPM. Rosuvastatin in the prevention of strokes among men and women with elevated C-reactive protein: Justification for Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). Circulation 2010;121:143-50.